Esophageal Diseases Clinical Trial
Official title:
Implementing Enhanced Recovery After Surgery (ERAS) Protocol in Patients Undergoing Minimal Invasive Esophagectomy
Detect impact of enhanced recovery after surgery (ERAS) on the outcomes of oesophageal surgery .
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | December 2027 |
Est. primary completion date | November 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 80 Years |
Eligibility | Inclusion Criteria: - 1) first detected and endoscopically confirmed esophageal cancer; 2)preoperative evaluation showed no distant metastases and suitable for MIE; 3preoperative clinical stage of I to III Exclusion Criteria: - 1) patients had a history of thoracic or abdominal surgery; 2)patients were IV to VI in the American Society of Anesthesiologists (ASA) physical status classification system; 3)patients had other malignancies; 4)patients had missing clinical data |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Puccetti F, Klevebro F, Kuppusamy M, Han S, Fagley RE, Low DE, Hubka M. Analysis of Compliance with Enhanced Recovery After Surgery (ERAS) Protocol for Esophagectomy. World J Surg. 2022 Dec;46(12):2839-2847. doi: 10.1007/s00268-022-06722-7. Epub 2022 Sep 22. — View Citation
Shen Y, Chen X, Hou J, Chen Y, Fang Y, Xue Z, D'Journo XB, Cerfolio RJ, Fernando HC, Fiorelli A, Brunelli A, Cang J, Tan L, Wang H; Written on behalf of the AME Thoracic Surgery Collaborative Group. The effect of enhanced recovery after minimally invasive esophagectomy: a randomized controlled trial. Surg Endosc. 2022 Dec;36(12):9113-9122. doi: 10.1007/s00464-022-09385-6. Epub 2022 Jun 30. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Enhanced recovery after surgery (ERAS) | Detect impact of enhanced recovery after surgery on the outcomes of oesophageal surgery concerning
time to out-of-bed activity time to first flatus time to liquid diet postoperative hospital stay ICU length of stay ICU length of stay in-hospital mortality incidence of various postoperative complications |
average 2 years | |
Secondary | Enhanced recovery after surgery (ERAS) | Detect impact of enhanced recovery after surgery on the outcomes of oesophageal surgery concerning
1)postoperative chest drainage volume |
average 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054933 -
Ultrasound Capsule Endoscopy for Esophagus Examination
|
N/A | |
Completed |
NCT04090554 -
Cytospongeâ„¢ Feasibility Study in Tanzania
|
N/A | |
Active, not recruiting |
NCT03962179 -
Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)
|
N/A | |
Completed |
NCT03549494 -
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
|
Phase 2 | |
Recruiting |
NCT04481100 -
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
|
Phase 2 | |
Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
Completed |
NCT00977678 -
Drop in Gastroscopy - Experience After 9 Months
|
N/A | |
Recruiting |
NCT04068480 -
Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy
|
||
Completed |
NCT00874263 -
Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies
|
N/A | |
Terminated |
NCT00442507 -
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
|
Phase 2 | |
Recruiting |
NCT03832959 -
Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.
|
N/A | |
Withdrawn |
NCT02569073 -
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
|
Phase 4 | |
Recruiting |
NCT05252078 -
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
|
Phase 2 | |
Recruiting |
NCT00260585 -
Esophageal Cancer Risk Registry
|
||
Completed |
NCT03187314 -
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
|
Phase 2 | |
Recruiting |
NCT05004155 -
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
|
||
Recruiting |
NCT05469152 -
Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases
|
N/A | |
Recruiting |
NCT05877300 -
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
|
Phase 1 | |
Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
Recruiting |
NCT05311787 -
The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery
|
N/A |